Back to search
SAM.govRef SSDS-11-4-2026-NCIRD-ID

A Virtual Network to Investigate the Clinical Epidemiology of Influenza and the Effectiveness of Influenza Vaccines

CCENTERS FOR DISEASE CONTROL AND PREVENTION logo
Contracting officeCenters for Disease Control and Prevention
PlanningServicesNAICS 541380
Submission deadlineDec 4, 202602:00 PM EST3 weeks left
PublishedNov 5, 2026
LocationATLANTA, GA
Notice type
Sources Sought
Product or service code
Q301 · REFERENCE LABORATORY TESTING
Set-aside
Not specified
Place of performance
ATLANTA, GA
Official notice
View on SAM.gov ↗

Description

Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services.

The rest of this notice

The buyer's named contact and the award details for this notice are free. Create an account to open the full record.

  • Contact the buyer directly
  • See who won, and for how much
  • Get alerts for opportunities like this one
Create a free account

Free — no card, no trial clock.

Get new Testing Laboratories and Services contracts by email — free, no card needed.
Create a free alert